Eli Lilly Reports Earnings Thursday as Investors Await Trump Drug Pricing Deal
The drugmaker Eli Lilly reports its third-quarter results early Thursday, as questions loom about what kind of deal it will reach with the Trump administration over the price of its weight-loss drug. Lilly shares are up about 5% this year. Compared with...
Barron's